DocuSign stock climbed on better-than-expected Q3 results and strong guidance for Q4 and fiscal 2025, leading to price target increases from analysts.
Latest Ratings for DOCU
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2022 | Piper Sandler | Maintains | Neutral | |
| Mar 2022 | Wolfe Research | Maintains | Peer Perform | |
| Mar 2022 | Wells Fargo | Maintains | Equal-Weight |
